Azide derivatized anticancer agents of Vitamin K3: X-ray structural, DSC, resonance spectral and API studies

被引:2
作者
Badave, Kirti [1 ]
Patil, Yogesh [1 ]
Gonnade, Rajesh [2 ]
Srinivas, Darbha [3 ]
Dasgupta, Rajan [4 ]
Khan, Ayesha [4 ]
Rane, Sandhya [1 ]
机构
[1] Univ Pune, Dept Chem, Pune 411007, Maharashtra, India
[2] Natl Chem Lab, Ctr Mat Characterizat, Pune 411008, Maharashtra, India
[3] Natl Chem Lab, Catalysis Div, Pune 411008, Maharashtra, India
[4] Univ Pune, Inst Bioinformat & Biotechnol, Pune 411007, Maharashtra, India
关键词
Electronic isomers; RAHB (resonance assisted H-bonding); API (Active Pharmaceutical Ingredients); Vitamin K-3; Anticancer agents; TAUTOMERIC COMPETITION; PACKING POLYMORPHISM; CRYSTAL-STRUCTURE; QUINONE METHIDE; METAL-COMPLEXES; CHEMISTRY; EXCHANGE; CELLS;
D O I
10.1016/j.molstruc.2011.09.022
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Compound 1 [1-imino (acetyl hydrazino)-Vitamin K-3], displays valence tautomerically related electronic isomers as Form land Form II. Form I exhibits 2D packing fragment with 1D ribbon chains of N-H center dot center dot center dot O hydrogen bonds and shows EPR silent features. While Form II is EPR active and exhibits biradical nature with double quantum transitions at g = 2.0040. H-1 NMR of compound 2, [1-imino (hydrazino carboxylate)-Vitamin K-3] and Form II exhibit pi delocalization via resonance assisted H-bonding [RAHB] effect compared to Form I. Molecular interactions in Form I and II are visualized by DSC. The electronic structures of compounds 1 and 2 have been correlated to their API values by measuring anticancer activities, mitochondrial potentials and DNA shearing patterns. Form II and compound 2 indicate mitochondria mediated apoptosis (similar to 75% cell death) while Form I causes 35% cell death. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:288 / 296
页数:9
相关论文
共 46 条
[1]   The potential of vitamin K3 as an anticancer agent against breast cancer that acts via the mitochondria-related apoptotic pathway [J].
Akiyoshi, Takeshi ;
Matzno, Sumio ;
Sakai, Mika ;
Okamura, Noboru ;
Matsuyama, Kenji .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 65 (01) :143-150
[2]   General synthesis, first crystal structure, and reactivity of stable o-quinone methide complexes of Cp*Ir [J].
Amouri, H ;
Besace, Y ;
Le Bras, J ;
Vaissermann, J .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1998, 120 (24) :6171-6172
[3]   Packing polymorphism of a conformationally flexible molecule (aprepitant) [J].
Braun, Doris E. ;
Gelbrich, Thomas ;
Kahlenberg, Volker ;
Laus, Gerhard ;
Wieser, Josef ;
Griesser, Ulrich J. .
NEW JOURNAL OF CHEMISTRY, 2008, 32 (10) :1677-1685
[4]   The hydrogen bond mimic approach:: Solid-phase synthesis of a peptide stabilized as an α-helix with a hydrazone link [J].
Cabezas, E ;
Satterthwait, AC .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1999, 121 (16) :3862-3875
[5]   STUDIES ON METAL-COMPLEXES OF ORTHO-QUINONE MONOOXIMES .9. ANALYSIS OF THE CHARGE-DISTRIBUTION WITHIN THE ORTHO-QUINONE MONOOXIME LIGANDS THROUGH CRYSTALLOGRAPHIC DATA [J].
CARUGO, O ;
DJINOVIC, K ;
RIZZI, M ;
CASTELLANI, CB .
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1991, (05) :1255-1258
[6]   Vitamin K: The coagulation vitamin that became omnipotent [J].
Cranenburg, Ellen C. M. ;
Schurgers, Leon J. ;
Vermeer, Cees .
THROMBOSIS AND HAEMOSTASIS, 2007, 98 (01) :120-125
[7]   Hydrogen bonding motif in 2-hydroxy-1,4-naphthoquinone [J].
Dhumal, NR ;
Todkary, AV ;
Rane, SY ;
Gejji, SP .
THEORETICAL CHEMISTRY ACCOUNTS, 2005, 113 (03) :161-166
[8]   Anticonvulsant properties of various acetylhydrazones, oxamoylhydrazones and semicarbazones derived from aromatic and unsaturated carbonyl compounds [J].
Dimmock, JR ;
Vashishtha, SC ;
Stables, JP .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (02) :241-248
[9]  
Drago R.S., 1992, PHYS METHODS CHEM, V2nd
[10]   Inhibitors of brain phospholipase A2 activity:: Their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders [J].
Farooqui, Akhlaq A. ;
Ong, Wei-Yi ;
Horrocks, Lloyd A. .
PHARMACOLOGICAL REVIEWS, 2006, 58 (03) :591-620